GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for terminal uridylyltransferase 4 (B2RX14)

Analyse AlphaFold monomer V2.0 prediction for terminal uridylyltransferase 4 (B2RX14) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B2RX14
Type
protein
Length
1,644 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x30FCf9cEE32bBC405ddE1AD7716F6606140F6706
Molecule
Terminal uridylyltransferase 4
UniProt
B2RX14
Pockets
15 · best druggability 0.81

Structure

1 distinct chain · 24% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATerminal uridylyltransferase 4protein164424% helix, 7% strandB2RX14

Pockets

15 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110880.810.82100empty
27790.730.7867empty
37630.660.7469empty
43600.620.7846empty
52430.490.7430empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.